Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) — The “ELISA Analyzer Market – Global Industry Size, Share, Trends, Competition, Opportunities and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com Dedication.
The ELISA Analyzer Market is expected to grow at an impressive CAGR during the forecast period 2024-2028
This can be attributed to factors such as the increasing demand for effective tests to diagnose the prevalence of infectious diseases and the growing demand for technologically advanced disease detection instruments.
Enzyme-linked immunosorbent assay (ELISA) is a laboratory test used to detect antibodies in the blood. ELISA is based on the principle of interaction between antibodies and antigens and is therefore used for disease diagnosis. Analyzers are automated instruments that perform different analytical steps and provide accurate and repeatable results.
In addition, the rising incidence of HIV, hepatitis, cancer, etc., and the increasing involvement of ELISA analyzers in research and development of immunology and drug development are driving the market demand for ELISA analyzers, thereby supporting market growth, which is expected to grow during the forecast period Push it within.
Rising prevalence of infectious diseases
The increasing prevalence of diseases among the population is driving the demand for ELISA analyzers in the market. The increasing prevalence of infectious diseases worldwide has caused significant health concerns for people around the world.
For example, according to the World Health Organization, 296 million people were infected with hepatitis B in 2019, with about 1.5 million new infections every year. Likewise, according to the World Health Organization, the global dengue disease burden has increased, with approximately 3.1 million cases observed, of which more than 25,000 are considered severe cases.
With the rapid increase in infectious diseases such as cancer, hepatitis, HIV, etc., the direct demand for diagnostics is surging, thus driving the market over the forecast period, thus contributing to the market growth.
Growing demand for technologically advanced tools in the field of immunization
Accuracy and rapid analysis of biochemical and immunological parameter maintenance are important requirements for the analysis of immunological test results. The analyzer is designed to ensure ideal performance of the assay, such as maintaining sensitivity, low background noise and fast reproducibility.
Additionally, ELISA analyzers such as the Open Systems Autoanalyzer come with pre-programmed test menus and simple guides that help save installation and provide user convenience. For example, in May 2022, Molecular Devices, LLC., a leading provider of high-performance life science solutions, launched an automated work cell for ELISA workflows.
The company introduces five new, off-the-shelf work cells for enzyme-linked immunosorbent assay (ELISA) workflows that offer automation qualities such as increased walk-away time and throughput, and less labor-intensive use in large samples Duplication of efforts is expected to lead to market growth in the coming years.
The growing need to measure enzyme activity
Measurement of enzyme activity and detection of soluble proteins, cytokines, and other protein bodies are driving the market demand for ELISA analyzers. Furthermore, the increase in allergy cases has led to the need for diagnostic techniques such as ELISA. ELISA is a diagnostic technique widely used to detect food allergies.
In addition, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in serum samples due to its simplicity and low cost compared with other automated systems. For example, in July 2018, Dynex Technologies announced a global partnership with ZEUS Scientific.
Market demand for ELISA analyzers has emerged with rising sales and rising demand for ELISA test kits during COVID-19, which is expected to boost the ELISA analyzer market during the forecast period.
recent developments
ELISA is used to quantify antibody titers and is further used to assess immunogenicity during vaccine development. Therefore, there is an increasing demand for ELISA analyzers from several companies engaged in vaccine development. For example, leading pharmaceutical company Sanofi Incorporation is developing 10 vaccine candidates, according to the latest update from its Q2 2022 earnings conference held in July 2022.
competitive landscape
Company Profiles: Detailed analysis of major players in the ELISA Analyzer market.
Reporting scope
ELISA Analyzer Market, By Type:
ELISA Analyzer Market, By Mode:
ELISA Analyzer Market by Application:
-
Immunology
-
vaccine development
-
drug monitoring
-
others
ELISA Analyzer Market, By End User:
ELISA Analyzer Market by Region:
-
North America
-
Europe
-
Asia Pacific
-
Middle East and Africa
-
South America
For more information about this report, please visit https://www.researchandmarkets.com/r/j1sbgo
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
